Get started
Author

Ana Krivokuća

Observed names: A Krivokuca, A. Krivokuca, AM Krivokuća, ANA M. KRIVOKUĆA, Ana Krivokuca, Ana M. Krivokuca, Ana M. Krivokuća, Krivokuca Ana, Krivoku|a Ana, Krivokuća, Ana, Krivokuća, Ana M.
ORCID: 0000-0002-1698-6981
Observed ORCID: 0000-0002-1698-6981
OpenAlex ID: A5021970446
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
2019 · Estefanía Moreno, Milena Cavic, et al. · Frontiers in Pharmacology · 127
PDF
Pregnancy After Breast Cancer in Young BRCA Carriers
2023 · Matteo Lambertini, Eva Blondeaux, et al. · JAMA · 64
PDF
Synthesis, antioxidant and antiproliferative activities of 1,3,4-thiadiazoles derived from phenolic acids
2017 · Katarina Jakovljević, Ivana Z. Matić, et al. · Bioorganic & Medicinal Chemistry Letters · 47
The Interplay between Cancer Biology and the Endocannabinoid System—Significance for Cancer Risk, Prognosis and Response to Treatment
2020 · Estefanía Moreno, Milena Cavic, et al. · Cancers · 34
PDF
Novel Selenosemicarbazone Metal Complexes Exert Anti-tumor Effect via Alternative, Caspase-independent Necroptotic Cell Death
2014 · Manja Zec, Tatjana Srdic-Rajic, et al. · Medicinal Chemistry · 33
Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy
2019 · Marko Jevrić, Ivana Z. Matić, et al. · BMC Cancer · 30
PDF
Highly selective anthraquinone-chalcone hybrids as potential antileukemia agents
2018 · Tatjana Stanojković, Violeta Marković, et al. · Bioorganic & Medicinal Chemistry Letters · 25
KRAS and BRAF mutations in Serbian patients with colorectal cancer.
2012 · K Jakovljevic, E Malisic, et al. · PubMed · 25
Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer
2018 · Miljana Tanić, Ana Krivokuća, et al. · Radiation Oncology · 23
PDF
Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
2022 · Gábor Cserni, Monika Francz, et al. · Pathology & Oncology Research · 21
PDF
Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients
2020 · Ana M. Vuletić, Gordana M. Konjević, et al. · European Cytokine Network · 21
PDF
Anticancer potential of new steroidal thiazolidin-4-one derivatives. Mechanisms of cytotoxic action and effects on angiogenesis in vitro
2017 · Marijana B. Živković, Ivana Z. Matić, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 21
Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women
2015 · Emina J. Malisic, Ana M. Krivokuca, et al. · Cancer Biomarkers · 21
PDF
Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia
2019 · Ana Krivokuca, Ivana Boljevic, et al. · Journal of Human Genetics · 20
Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer
2020 · Bojana Uzelac, Ana Krivokuca, et al. · Pathology & Oncology Research · 19
TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool
2018 · Milena Cavic, Jelena Spasic, et al. · Journal of Clinical Pathology · 19
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals
2020 · Milena Cavic, Ana Krivokuca, et al. · Expert Review of Molecular Diagnostics · 18
Polymorphisms in Cancer Susceptibility Genes XRCC1, RAD51 and TP53 and the Risk of Breast Cancer in Serbian Women
2016 · Ana M. Krivokuca, Milena R. Cavic, et al. · The International Journal of Biological Markers · 17
Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy
2024 · Jelena Grahovac, Ana Đurić, et al. · International Journal of Molecular Sciences · 16
PDF
Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.
2017 · Milena Cavic, Ana Krivokuca, et al. · PubMed · 16
RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women
2013 · Ana M. Krivokuca, Emina J. Malisic, et al. · Familial Cancer · 16
Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
2019 · Zoran Kozomara, Gordana Supic, et al. · PubMed · 15
3D HeLa spheroids as a model for investigating the anticancer activity of Biginelli-hybrids
2021 · Marija Đorđić Crnogorac, Ivana Z. Matić, et al. · Chemico-Biological Interactions · 13
Serbian high-risk families: extensive results on BRCA mutation spectra and frequency
2013 · Jelena Dobričić, Ana Krivokuća, et al. · Journal of Human Genetics · 13
The Usability of Allele-Specific PCR and Reverse-Hybridization Assays for KRAS Genotyping in Serbian Colorectal Cancer Patients
2012 · Ksenija Brotto, Emina Malisic, et al. · Digestive Diseases and Sciences · 13
Works count: 86
Citation count: 815
H-index: 17
I10-index: 26
Year
Topic
Type